1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global PCR and NGS-Based Molecular Diagnostics Market Size Growth Rate by Type: 2018 VS 2022 VS 2032
1.2.2 Biomarker Discovery
1.2.3 Blood Sample Testig
1.2.4 Others
1.3 Market by Application
1.3.1 Global PCR and NGS-Based Molecular Diagnostics Market Share by Application: 2018 VS 2022 VS 2032
1.3.2 Hospitals
1.3.3 Academics/Research Institutions
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global PCR and NGS-Based Molecular Diagnostics Market Perspective (2018-2032)
2.2 PCR and NGS-Based Molecular Diagnostics Growth Trends by Region
2.2.1 PCR and NGS-Based Molecular Diagnostics Market Size by Region: 2018 VS 2022 VS 2032
2.2.2 PCR and NGS-Based Molecular Diagnostics Historic Market Size by Region (2018-2023)
2.2.3 PCR and NGS-Based Molecular Diagnostics Forecasted Market Size by Region (2023-2032)
2.3 PCR and NGS-Based Molecular Diagnostics Market Dynamics
2.3.1 PCR and NGS-Based Molecular Diagnostics Industry Trends
2.3.2 PCR and NGS-Based Molecular Diagnostics Market Drivers
2.3.3 PCR and NGS-Based Molecular Diagnostics Market Challenges
2.3.4 PCR and NGS-Based Molecular Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top PCR and NGS-Based Molecular Diagnostics Players by Revenue
3.1.1 Global Top PCR and NGS-Based Molecular Diagnostics Players by Revenue (2018-2023)
3.1.2 Global PCR and NGS-Based Molecular Diagnostics Revenue Market Share by Players (2018-2023)
3.2 Global PCR and NGS-Based Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by PCR and NGS-Based Molecular Diagnostics Revenue
3.4 Global PCR and NGS-Based Molecular Diagnostics Market Concentration Ratio
3.4.1 Global PCR and NGS-Based Molecular Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by PCR and NGS-Based Molecular Diagnostics Revenue in 2022
3.5 PCR and NGS-Based Molecular Diagnostics Key Players Head office and Area Served
3.6 Key Players PCR and NGS-Based Molecular Diagnostics Product Solution and Service
3.7 Date of Enter into PCR and NGS-Based Molecular Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 PCR and NGS-Based Molecular Diagnostics Breakdown Data by Type
4.1 Global PCR and NGS-Based Molecular Diagnostics Historic Market Size by Type (2018-2023)
4.2 Global PCR and NGS-Based Molecular Diagnostics Forecasted Market Size by Type (2023-2032)
5 PCR and NGS-Based Molecular Diagnostics Breakdown Data by Application
5.1 Global PCR and NGS-Based Molecular Diagnostics Historic Market Size by Application (2018-2023)
5.2 Global PCR and NGS-Based Molecular Diagnostics Forecasted Market Size by Application (2023-2032)
6 North America
6.1 North America PCR and NGS-Based Molecular Diagnostics Market Size (2018-2032)
6.2 North America PCR and NGS-Based Molecular Diagnostics Market Size by Country (2018-2023)
6.3 North America PCR and NGS-Based Molecular Diagnostics Market Size by Country (2023-2032)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe PCR and NGS-Based Molecular Diagnostics Market Size (2018-2032)
7.2 Europe PCR and NGS-Based Molecular Diagnostics Market Size by Country (2018-2023)
7.3 Europe PCR and NGS-Based Molecular Diagnostics Market Size by Country (2023-2032)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific PCR and NGS-Based Molecular Diagnostics Market Size (2018-2032)
8.2 Asia-Pacific PCR and NGS-Based Molecular Diagnostics Market Size by Country (2018-2023)
8.3 Asia-Pacific PCR and NGS-Based Molecular Diagnostics Market Size by Country (2023-2032)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America PCR and NGS-Based Molecular Diagnostics Market Size (2018-2032)
9.2 Latin America PCR and NGS-Based Molecular Diagnostics Market Size by Country (2018-2023)
9.3 Latin America PCR and NGS-Based Molecular Diagnostics Market Size by Country (2023-2032)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa PCR and NGS-Based Molecular Diagnostics Market Size (2018-2032)
10.2 Middle East & Africa PCR and NGS-Based Molecular Diagnostics Market Size by Country (2018-2023)
10.3 Middle East & Africa PCR and NGS-Based Molecular Diagnostics Market Size by Country (2023-2032)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Thermofisher
11.1.1 Thermofisher Company Detail
11.1.2 Thermofisher Business Overview
11.1.3 Thermofisher PCR and NGS-Based Molecular Diagnostics Introduction
11.1.4 Thermofisher Revenue in PCR and NGS-Based Molecular Diagnostics Business (2018-2023)
11.1.5 Thermofisher Recent Development
11.2 Illumine
11.2.1 Illumine Company Detail
11.2.2 Illumine Business Overview
11.2.3 Illumine PCR and NGS-Based Molecular Diagnostics Introduction
11.2.4 Illumine Revenue in PCR and NGS-Based Molecular Diagnostics Business (2018-2023)
11.2.5 Illumine Recent Development
11.3 Paragon Genomics
11.3.1 Paragon Genomics Company Detail
11.3.2 Paragon Genomics Business Overview
11.3.3 Paragon Genomics PCR and NGS-Based Molecular Diagnostics Introduction
11.3.4 Paragon Genomics Revenue in PCR and NGS-Based Molecular Diagnostics Business (2018-2023)
11.3.5 Paragon Genomics Recent Development
11.4 Roche
11.4.1 Roche Company Detail
11.4.2 Roche Business Overview
11.4.3 Roche PCR and NGS-Based Molecular Diagnostics Introduction
11.4.4 Roche Revenue in PCR and NGS-Based Molecular Diagnostics Business (2018-2023)
11.4.5 Roche Recent Development
11.5 Qiagen
11.5.1 Qiagen Company Detail
11.5.2 Qiagen Business Overview
11.5.3 Qiagen PCR and NGS-Based Molecular Diagnostics Introduction
11.5.4 Qiagen Revenue in PCR and NGS-Based Molecular Diagnostics Business (2018-2023)
11.5.5 Qiagen Recent Development
11.6 Bioo Scientific
11.6.1 Bioo Scientific Company Detail
11.6.2 Bioo Scientific Business Overview
11.6.3 Bioo Scientific PCR and NGS-Based Molecular Diagnostics Introduction
11.6.4 Bioo Scientific Revenue in PCR and NGS-Based Molecular Diagnostics Business (2018-2023)
11.6.5 Bioo Scientific Recent Development
11.7 Agilent
11.7.1 Agilent Company Detail
11.7.2 Agilent Business Overview
11.7.3 Agilent PCR and NGS-Based Molecular Diagnostics Introduction
11.7.4 Agilent Revenue in PCR and NGS-Based Molecular Diagnostics Business (2018-2023)
11.7.5 Agilent Recent Development
11.8 Pillar Biosciences
11.8.1 Pillar Biosciences Company Detail
11.8.2 Pillar Biosciences Business Overview
11.8.3 Pillar Biosciences PCR and NGS-Based Molecular Diagnostics Introduction
11.8.4 Pillar Biosciences Revenue in PCR and NGS-Based Molecular Diagnostics Business (2018-2023)
11.8.5 Pillar Biosciences Recent Development
11.9 LC-Bio Technologies (Hangzhou) CO. LTD.
11.9.1 LC-Bio Technologies (Hangzhou) CO. LTD. Company Detail
11.9.2 LC-Bio Technologies (Hangzhou) CO. LTD. Business Overview
11.9.3 LC-Bio Technologies (Hangzhou) CO. LTD. PCR and NGS-Based Molecular Diagnostics Introduction
11.9.4 LC-Bio Technologies (Hangzhou) CO. LTD. Revenue in PCR and NGS-Based Molecular Diagnostics Business (2018-2023)
11.9.5 LC-Bio Technologies (Hangzhou) CO. LTD. Recent Development
11.10 iGen Technologies
11.10.1 iGen Technologies Company Detail
11.10.2 iGen Technologies Business Overview
11.10.3 iGen Technologies PCR and NGS-Based Molecular Diagnostics Introduction
11.10.4 iGen Technologies Revenue in PCR and NGS-Based Molecular Diagnostics Business (2018-2023)
11.10.5 iGen Technologies Recent Development
11.11 Burning Rock
11.11.1 Burning Rock Company Detail
11.11.2 Burning Rock Business Overview
11.11.3 Burning Rock PCR and NGS-Based Molecular Diagnostics Introduction
11.11.4 Burning Rock Revenue in PCR and NGS-Based Molecular Diagnostics Business (2018-2023)
11.11.5 Burning Rock Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
